baber/WOPTO huggingface dataset:
Patent FI-934938-A0 (FI)
Inventor: TUCKER RONALD
IPC: B65B7/18
Filed: 1993-11-08
Abstract: An apparatus for sterilizing and breaking score lines on cartons prior to filling includes a spraying assembly (31) for spraying sterilizing solution into the interior of the carton (10) and a score line breaking assembly (50) that breaks the score lines on the upstanding walls of the carton. The spraying assembly (31) and the score line breaking assembly (50) are located at the same station within a filling machine so that both operations can be performed simultaneously. The spray assembly (31) includes a movably mounted spray head (32) that is provided with a spray nozzle (34). The score line breaking assembly (50) includes a breaker member (52) that is operatively connected to a drive assembly (56) for driving the breaker member into contacting relation with the upper portion of the upstanding walls of a carton in order to urge the upstanding walls of the carton inwardly and thereby break the score lines on the carton walls. An anvil (62) on the spray head (32) is positioned to cooperate with the breaker member (52) to cause initial folding of the walls of the carton when the spray head (32) is lowered into the carton (10). <IMAGE>
Patent FI-940406-A0 (FI)
Inventor: STORECK ARNOLD
IPC: D21H17/68
Filed: 1994-01-27
Abstract: Paper is filled with synthetic silica, which can have been precipitated, spray-dried and ground. <IMAGE>
Patent FI-940680-A0 (FI)
Inventor: CRHISTOPHE BERNARD
IPC: A61K31/18
Filed: 1994-02-14
Abstract: The subject of the invention is compounds of formula I <IMAGE>  in which   Ar1 represents optionally substituted naphthyl, phenyl, quinolyl or isoquinolyl;   Ar2 represents optionally substituted phenyl or thienyl; R1, R2 and R'2 represent, independently of each other, H, (C1-C4)alkyl or R1 represents nothing and N is linked to Ar2 and, optionally, R2 and R'2 form a double bond,   or R1 or R2 is linked to Ar2 and represents (C1-C3)alkylene; R3 and R4, which are identical or different, represent H, (C1-C4)alkyl or form with the nitrogen atom to which they are attached a saturated (C5-C7)heterocycle;   Z1 represents (C1-C12)alkylene; Q1 represents methyl, amino, (C1-C4)alkoxycarbonylamino, (C1-C4)alkylamino, di(C1-C4)alkylamino, pyrrolidinyl, piperidino, morpholino, piperazinyl, 4-(C1-C4)alkyl piperazinyl, amidino, (C1-C4)alkylamidino, guanidino, (C1-C4)alkylguanidino, pyridyl, imidazolyl, pyrimidinyl, indolyl, hydroxyl, (C1-C4)alkoxy, (C2-C8)alkoxycarbonyl, amino(C1-C4)alkyl-N-(C1-C4)alkylamino, carbamoyl or phenyl which is optionally substituted;   Q2 represents H or (C1-C4)alkyl; Q3 represents H or (C1-C4)alkyl or Q1 and Q3 are linked to form a heterocycle and represent together (C2-C3)alkylene whereas Z1 represents nothing, in the form of pure enantiomers or of mixtures thereof in any proportions,  as well as their salts with acids. These compounds have an affinity for the biological receptors of neuropeptide Y (NPY) which are present in the central and peripheral nervous systems.
Patent FI-942847-A0 (FI)
Inventor: HAHN WILFRIED
IPC: C12N9/98
Filed: 1994-06-15
Abstract: Liquid enzyme preparations which contain the enzyme as aqueous enzyme particle suspension, highly disperse fillers and a liquid alkylene oxide polymer based on ethylenediamine with a molecular weight in the range from 500 to 8200 are described. The liquid enzyme preparations may contain all enzymes customary for detergents and cleaning purposes, in particular alkaline proteases. Furthermore, a process for the production of these liquid enzyme preparations and the use thereof in liquid detergents and cleaners are described.
Patent FI-944934-A0 (FI)
Inventor: JEAN BUFORD RANDALL
IPC: G01N22/04
Filed: 1994-10-20
Abstract: The present invention provides an apparatus and method for the measurement of, for example, the moisture in a material or, more generally, for the measurement of any material parameter which may be inferred by measuring the electromagnetic properties of the material under investigation. The electromagnetic properties of use in the present invention are complex electrical permittivity or the magnetic permeability of the material. The meter apparatus of the present invention comprises a controllable source of electromagnetic energy having stable selectable frequency. The controllable source of electromagnetic energy is coupled to a material measurement chamber by means of probes, loops, antennas, apertures or other structures so as to establish an electromagnetic wave inside the measurement chamber thereby causing the wave to interact with the material contained in the chamber. Its preferred structure comprises coupling of microwave energy from a coaxial transmission line to the measurement chamber over a multi-octave bandwidth via an intermediate microstrip to slotline coupling circuit.
Patent FI-964939-A0 (FI)
Inventor: LEHTINEN JUKKA
IPC: D21F5/00
Filed: 1996-12-10
Abstract: The invention relates to a method of and an apparatus for drying a fiber web, whereby the fiber web is dried in a cylinder drying unit (12) and in a band drier unit (11). The fiber web (5) is led from the cylinder drying unit (12) to the band drier unit (11) in such a way that it is easy to determine a desired dry content for the fiber web (5) in the cylinder drying unit (12) when the fiber web (5) is transferred to the band drier unit (11).
Patent FI-972928-A0 (FI)
Inventor: ARAMBURU LUIS ANGEL RUANO
IPC: E05B35/00
Filed: 1997-07-10
Abstract: The lock cylinder has a toothed edge key (1). One of the edges (1b) contains a series of protrusions and recesses forming a combination with tumbler pins (14) spring-loaded inside a stator (2) and rotor (3) which form part of the cylinder. A blind recess (7) in the untoothed edge (1a) accommodates a relatively strong compression spring (9) and a security tumbler pin (8) moving between extended and retracted positions. When the correct key is inserted, this pin is radially aligned and in contact with a mating pin (10) in a seat in the stator via the opening (13) in a plate (12) inserted in the rotor. The thickness of the plate is equal to the difference between the radii of the untoothed edge (4) and that (5) of the outside of the rotor. In the lengthwise direction, the position of the pins does not coincide with that of the tumbler pins (14) of the main combination.
Patent IL-70263-A0 (IL)
Title: Implement for descent along a rope
IPC: A62B1/14
Filed: 1983-11-17
Abstract: A device for lowering a person or a load on a rope which automatically arrests further movement of the person or load on the rope regardless of which direction the rope passes through the device, which is capable of accommodating ropes of different diameters. The device of this invention includes a friction cylinder disposed on a base plate, a friction body, and a pivotally mounted control lever. The rope is wrapped around at least a portion of the circumference of the friction cylinder and also around the friction body, and the rope thereafter passes between a concave braking surface disposed on the friction body and one end of the control lever. The end of the control lever is provided with two camming surfaces which are positioned on opposite sides of the axis of rotation of the lever. Regardless of the direction of movement of the rope, friction between one of the camming surfaces and the rope causes the rope to be wedged between that camming surface and the concave braking surface on the friction body. Free movement of the rope is permitted by manually positioning the lever in an intermediate position so that both camming surfaces are spaced from the concave braking surface.
Patent IL-86388-A0 (IL)
Title: Preparation of tc-99m radio-pharmaceuticals
IPC: A61K51/00
Filed: 1988-05-15
Abstract: Complexes useful as radiopharmaceuticals contain the <99m>Tc-NO moiety and a ligand which confers biological target-seeking properties on the complex. Preferred are mono-cationic complexes, particularly having the formula      [<99m>Tc(NO)L2X]<+> where X is halide or pseudohalide and L is a bidentate ligand for Technetium, which have interesting properties for use as heart visualising agents. Examples of ligands include di-(dialkyl and diphenyl)-phosphinoethanes and o-phenylenebisdimethylarsine. The complexes may be made by reacting generator eluate pertechnetate with a hydroxylamine salt and with the ligands, preferably in a single step by providing a reaction mixture containing the three reagents optionally in the presence of a reducing agent.
Patent IL-93559-A0 (IL)
Title: Preparation of anthracyclinones
IPC: C07C50/38
Filed: 1990-02-27
Abstract: Process for preparing anthracyclinones of general formula (I): <CHEM> wherein R represents a hydrogen atom or a COOR1 group in which R1 may be a hydrogen atom or an optionally substituted C1-C10 alkyl group, which are intermediates in the preparation of antitumor anthracycline glycosides, are prepared by:   (i)(a) reacting a 4-demethyl-4-sulfonyl-7-deoxy-13-dioxolanyl daunomycinone of formula (V): <CHEM> wherein R min  represents an alkyl group having from 1 to 10 carbon atoms optionally substituted by one or more halogen atoms or an aryl group optionally substituted by halogen, alkyl, alkoxy or nitro, in a reducing environment with a catalytic amount of a compound of formula (VIII):  MLnL min m wherein M represents a transition metal atom, L and L min , which may be the same or different, each represent an anion or a neutral molecule and n and m may vary from 0 to 4, such as to obtain a compound of formula (VII): <CHEM>  wherein R represents hydrogen; or (b) carbonylating a 4-demethyl-4-sulfonyl-7-deoxy-13-dioxolanyl daunomycinone of formula (V) as defined above, with carbon monoxide in the presence of a nucleophile R1OH wherein R1 is as defined above, an organic or inorganic base and as catalyst a compound of formula (VIII) as defined above, such as to obtain a compound of formula (VII) as shown above wherein R represents a COOR1 group; and (ii) introducing an  alpha -hydroxy group at the 7-position and removing the 13-oxo protecting group by acid hydrolysis from the resultant compound of formula (VII). r
Patent IL-94278-A0 (IL)
Title: 2-saccharine derivatives,their preparation and pharmaceutical compositions containing them
IPC: C07D275/06
Filed: 1990-05-03
Abstract: Novel 2-substituted saccharin derivatives useful as proteolytic enzyme inhibitors, compositions containing the same for the treatment of degenerative diseases and method of use thereof.
Patent AU-PN114095-A0 (AU)
Title: A press for drying parts of plants using microwave energy
IPC: F26B3/347
Filed: 1995-02-14
Abstract: A plant drying press for use in a microwave oven wherein plant material is held between absorbent sheets (14) backed by vapour permeable pads (12) with the assembly clamped between plattens (11) held by clips (15). The permeable pads (12) are ideally resilient. The plattens (11) are plate-like, ideally with ribs (17-20) and perforated (13, 21). The platens (11), pads (12) and sheets (14) are ideally microwave transparent.
Patent AU-PR066700-A0 (AU)
Title: Waste treatment
IPC: B02C19/18
Filed: 2000-10-10
Abstract: Disclosed is an improved cutting mechanism (108) for shredding waste comprising a rotatable planetary gear box (110) having a drive shaft (125) and a plurality of planet gears each of which drives a rotating cutting head (109) characterised in that rotation of the drive shaft (125) rotates the planetary gear box (110) in one direction (126) and each of the cutting heads (109) in the opposite direction (127).
Patent FI-20035204-A0 (FI)
Inventor: TARPIO TAPIO
IPC: F16L55/027
Filed: 2003-11-12
Abstract: The invention relates to a sound trap (1) arranged to be installed in a ventilation duct (6). The sound trap (1) comprises a housing (4), a sound attenuating piece (5) made of a sound absorbing material, at least one inlet (2) for conveying air into the sound trap (1), and at least one outlet (3) for conducting air out of the sound trap (1). Furthermore, the sound trap comprises at least one flow channel (7) for conducting air from said at least one inlet (2) to said at least one outlet (3). The sound attenuating piece (5) is placed between the inlet (2) and the outlet (3) so that a direct air flow from the inlet (2) to the outlet (3) is blocked, wherein the air at least partly circumvents the sound attenuating piece (5), and said at least one flow channel (7) is provided in the volume limited by the sound attenuating piece (5) and the housing (7). <IMAGE>
Patent IL-106795-A0 (IL)
Title: Communication channel switching arrangement
IPC: H04M3/18
Filed: 1993-08-25
Abstract: PCT No. PCT/GB93/01717 Sec. 371 Date Feb. 24, 1995 Sec. 102(e) Date Feb. 24, 1995 PCT Filed Aug. 13, 1993 PCT Pub. No. WO94/05108 PCT Pub. Date Mar. 3, 1994A maintenance termination unit (MTU) for use in telephone circuits. The MTU comprises a switching arrangement which can be connected in a communications channel, the communications channel comprising a pair of lines. The switching arrangement is connected between a set of exchange-side terminal equipment and a set of subscriber-side terminal equipment. The arrangement comprises first and second line switches, each of which is series connected in one of the lines. Each line switch comprises a control terminal, and has a closed state in which it will pass normal line current, and an open state in which it will pass at most a reduced line current. The arrangement also comprises a control circuit which is connected to the channel between the line switches and the subscriber-side terminal equipment. The control circuit comprises: a charge reservoir which is connected between the lines; a reservoir charging switch which is connected in series with the charge reservoir and controls the charging of the reservoir in response to a signal on the lines; and a reservoir discharging switch which is controlled by a signal on the lines and will allow the reservoir, when charged, to energize the control terminals of the line switches so that, when the line switches are opened by the control circuit, the line switches can be maintained in an open state for a period of time by discharging the reservoir.
Patent IL-122645-A0 (IL)
Title: Method of purification by extraction from a liquid medium
IPC: C01B25/223
Filed: 1996-06-21
Abstract: PCT No. PCT/BE96/00066 Sec. 371 Date Feb. 5, 1998 Sec. 102(e) Date Feb. 5, 1998 PCT Filed Jun. 21, 1996 PCT Pub. No. WO97/00714 PCT Pub. Date Jan. 9, 1997Method of purification by extraction of at least one substance to be isolated from a liquid medium, comprising an addition to the latter of an organic compound, entrainable by a vapor, which has a molecule with an acidic-basic character in the Lewis sense due to at least one atom of N, O and/or S forming one or more active sites provided with a free electron pair, this pair or these pairs being in resonance with at least one other pair carried by the molecule, this addition being carried out in a quantity sufficient to give rise to a product of an equilibrium reaction between the organic compound and the said at least one substance to be isolated, and sufficient to cause a precipitation of this equilibrium reaction product, a filtration of the precipitate and an entrainment by vapor of the organic compound from the precipitate, with a yield of the substance to be isolated in purified form.
Patent IL-127191-A0 (IL)
Title: Decorative eyeglasses
IPC: G02C5/14
Filed: 1997-03-14
Abstract: Eyeglasses having a lens-carrying frame and temple pieces mounted to the lens-carrying frame, the temple pieces including a temple block hinged to the frame, ear pieces, and, between the block and the ear pieces, a segment mounted on the hinge block, but rotatably mounted with respect to the frame. The rotatable section can be made in various shapes, or imprinted with various different decorations on different sides, or made varicolored.
Patent IL-128877-A0 (IL)
Title: Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
IPC: C07D491/048
Filed: 1998-07-09
Abstract: A method for treating cognitive impairments associated with aging or Alzheimer's disease which comprises treating a patient at risk for having the cognitive impairment with an effective amount of a highly selective butyrylcholinesterase inhibitor which is N<8>-benzylnorcymserine, N<1>-phenethylnorcymserine, N<1>, N<8>-bisnorcymserine, N<1>-N<8>-bisbenzylnorphysostigmine, N<1>, N<8>-bisbenzylnorphenserine, N<1>, N<8>-bisbenzylnorcymserine, or pharmaceutical acceptable salts thereof.
Patent IL-134892-A0 (IL)
Title: Inorganic nanoparticles and metal matrices utilizing the same
IPC: C10N50/08
Filed: 2000-03-06
Abstract: The present invention provides a new composite material comprising a porous matrix made of metal, metal alloy or semiconducting material and hollow fullerene-like nanoparticles of a metal chalcogenide compound or mixture of such compounds. The composite material is characterized by having a porosity between about 10% and about 40%. The amount of the hallow nanoparticles in the composite material is 1-20 wt. %.
Patent IL-143300-A0 (IL)
Title: Method and device for selecting accelerated proliferation of living cells in suspension
IPC: C12M1/00
Filed: 1999-12-02
Abstract: The present invention relates to a method and a device for selecting accelerated proliferation of living cells in suspension. The culture apparatus (2) of the present invention enables cells to proliferate in suspension over unlimited periods of time. Natural selection results in the accumulation of genetic variants which are increasingly better adapted to the chosen culture conditions. The organisms used can be prokaryotic or eukaryotic. The organisms used can be naturally occurring organisms or genetically modified organisms. The culture apparatus of the present invention is also suitable for using continuous, periodical or conditional culture conditions. The physical and chemical characteristics of the culture media used can be chosen by the user. The requirement that a population of cells proliferates exclusively in suspension in continuous culture conditions is satisfied by the periodical transfer of the organism suspension from a first culture vessel into a second culture vessel. After the transfer, the first culture vessel is subjected to a sterilizing treatment and the sterilizing agent is optionally neutralized, so that the first culture vessel is ready for the culture to be transferred back from the second culture vessel. The second culture vessel is then sterilized and neutralized.
Patent IL-147249-A0 (IL)
Title: Epitopes formed by non-covalent association of conjugates
IPC: A61K9/127
Filed: 2000-06-27
Abstract: A composition for interacting with a ligand, which composition comprises anon-covalent association of a plurality of distinct conjugates, each conjugate comprising a head group and a tail group, wherein the tail groups of the conjugates form a hydrophobic aggregation and the conjugates are movable within the association so that, in the presence of a ligand, at least two of the head groups are appropriately positioned to form an epitope capable of interacting with the ligand more strongly than each of head groups individually.
Patent IL-151378-A0 (IL)
Title: Humanized antibodies that sequester amyloid beta peptide
IPC: A61P/
Filed: 2001-02-26
Abstract: A method to treat conditions characterized by formation of amyloid plaques both grophylactically and therapeutically is described. The method employs humanized antibodies which sequester soluble Aß peptide from human biological fluids or which preferably specifically bind an epitope contained within position 13-28 of the amyloid beta peptide Aß.
Patent IL-160178-A0 (IL)
Title: Combinations of dmxaa and other anti-cancer agents
IPC: A61K31/505
Filed: 2002-09-03
Abstract: The present invention relates to synergistic combinations of the compound 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and a compound selected from platinum compounds, vinca alkaloids, alkylating agents, anthracyclines, topoisomerase I inhibitors, antimetabolites and topoisomerase II inhibitors, which have anti-tumour activity. More particularly, the invention is concerned with the use of such combinations in the treatment of cancer and pharmaceutical compounds containing said combinations.
Patent IL-160303-A0 (IL)
Title: Pesticidal and parasitical di-and trifluorosubstituted alkene compounds
IPC: A61K31/437
Filed: 2002-09-09
Abstract: Di- and trifluorosubstituted alkene compounds of formula I wherein X is hydrogen or fluorine; Y is oxygen, NR<SUP>1 </SUP>or S(O)<SUB>m</SUB>; R<SUP>1 </SUP>is hydrogen or C<SUB>1</SUB>-C<SUB>6</SUB>-alkyl; m is 0, 1, or 2; A,B,D and E are selected from the following: a) A is N and B, D and E are CR<SUP>2</SUP>; or b) B is N and A, D and E are CR<SUP>2</SUP>; or c) D is N and A, B, and E are CR<SUP>2</SUP>; or d) A and D are N and B and E are CR<SUP>2</SUP>; or e) B and E are N and A and D are CR<SUP>2</SUP>; R<SUP>2 </SUP>is H, halogen, NH<SUB>2</SUB>, NO<SUB>2</SUB>, CN, alkyl, haloalkyl, alkenyl, alkoxy, haloalkoxy, alkylthio, haloalkylthio, alkylsulfinyl, haloalkylsulfinyl, alkylsulfonyl, haloalkylsulfonyl, aminosulfonyl, alkoxyalkyl, alkylthioalkyl, alkylsulfinylalkyl, alkylsulfonylalkyl,alkylaminoalkyl, dialkylaminoalkyl, hydroxycarbonyl, or alkoxycarbonyl; or phenyl which may be substituted with halogen, CN, NO<SUB>2</SUB>, alkyl, haloalkyl, alkoxy, or haloalkoxy; or a 5- to 6-membered heteroaromatic ring system containing 1 to 3 heteroatoms selected from oxygen, sulfur and nitrogen, which may be substituted with halogen, CN, NO<SUB>2</SUB>, alkyl, haloalkyl, alkoxy, or haloalkoxy; n is 1, 2, 3 or 4, and the agriculturally and/or physiologically tolerable salts thereof, methods for the preparation of compounds I, and compositions and methods for the control of nematodes and arachnids, and for treating, controlling, preventing and protecting warm-blooded animals, fish and humans against infestation and infection by helminths, arachnids and arthropod endo- and ectoparasites.
Patent IL-180754-A0 (IL)
Title: Elliptical intraluminal surgical stapler for anastomosis
Filed: 2007-01-17
Abstract: A surgical stapler includes a head in which a plurality of staples are stored. The head includes a facing surface. The stapler also includes an anvil having an anvil surface shaped and dimensioned for forming the staples upon actuation of the surgical stapler, the anvil including a facing surface opposed to the facing surface of the head for mating engagement therewith. The facing surface of the head is obliquely oriented relative to a longitudinal axis of the head creating an elliptical staple line when the head is brought into contact with anvil during actuation of the surgical stapler.
Patent IL-186641-A0 (IL)
Title: Use of selective chloride channel modulators to treat alcohol and/or stimulant substance abuse
IPC: A61K31/551
Filed: 2007-10-14
Abstract: The invention relates to methods of and treatments for using pharmaceutical compositions from a class of compounds that directly or indirectly selectively modulates GABAA chloride channel activity to treat alcohol and/or stimulant substance abuse. The present invention also relates to methods of, and protocols for, relieving symptoms associated with alcohol and/or stimulant substance abuse in a comprehensive treatment plan. More specifically, the present invention relates to the use of a selective chloride channel modulator, such as flumazenil, to treat alcohol and/or psychostimulant dependency, the withdrawal symptoms associated therewith, and the cravings associated therewith.
Patent IL-193665-A0 (IL)
Title: Integration of a starter/generator module in a gas turbine transmission housing
Filed: 2008-08-25
Abstract: A starter/generator mechanically coupled to a gas turbine transmission housing is disclosed. The starter/generator includes a generator with a rotor forming a field winding and a stator forming an armature, and an energizer with a stator forming a field winding and a rotor forming an armature connected to the generator field winding. The generator rotor and the energizer rotor are mounted on a common shaft with a transmission housing gear wheel, on either side of the gear wheel.